These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35902495)
21. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery. Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481 [TBL] [Abstract][Full Text] [Related]
22. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750 [TBL] [Abstract][Full Text] [Related]
23. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma. Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759 [TBL] [Abstract][Full Text] [Related]
24. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis. Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364 [TBL] [Abstract][Full Text] [Related]
25. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701 [TBL] [Abstract][Full Text] [Related]
26. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Veronesi U; Paganelli G; Viale G; Luini A; Zurrida S; Galimberti V; Intra M; Veronesi P; Maisonneuve P; Gatti G; Mazzarol G; De Cicco C; Manfredi G; Fernández JR Lancet Oncol; 2006 Dec; 7(12):983-90. PubMed ID: 17138219 [TBL] [Abstract][Full Text] [Related]
27. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412 [TBL] [Abstract][Full Text] [Related]
28. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. Montagna G; Mrdutt MM; Sun SX; Hlavin C; Diego EJ; Wong SM; Barrio AV; van den Bruele AB; Cabioglu N; Sevilimedu V; Rosenberger LH; Hwang ES; Ingham A; Papassotiropoulos B; Nguyen-Sträuli BD; Kurzeder C; Aybar DD; Vorburger D; Matlac DM; Ostapenko E; Riedel F; Fitzal F; Meani F; Fick F; Sagasser J; Heil J; Karanlik H; Dedes KJ; Romics L; Banys-Paluchowski M; Muslumanoglu M; Perez MDRC; Díaz MC; Heidinger M; Fehr MK; Reinisch M; Tukenmez M; Maggi N; Rocco N; Ditsch N; Gentilini OD; Paulinelli RR; Zarhi SS; Kuemmel S; Bruzas S; di Lascio S; Parissenti TK; Hoskin TL; Güth U; Ovalle V; Tausch C; Kuerer HM; Caudle AS; Boileau JF; Boughey JC; Kühn T; Morrow M; Weber WP JAMA Oncol; 2024 Jun; 10(6):793-798. PubMed ID: 38662396 [TBL] [Abstract][Full Text] [Related]
29. Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy. Geertsema D; Gobardhan PD; Madsen EV; Albregts M; van Gorp J; de Hooge P; van Dalen T Ann Surg Oncol; 2010 Oct; 17(10):2690-5. PubMed ID: 20422461 [TBL] [Abstract][Full Text] [Related]
30. How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study. Weiss A; King C; Grossmith S; Portnow L; Raza S; Nakhlis F; Dominici L; Barbie T; Minami C; Nimbkar S; Rhei E; Mittendorf EA; King TA Ann Surg Oncol; 2022 Jun; 29(6):3764-3771. PubMed ID: 35041097 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377 [TBL] [Abstract][Full Text] [Related]
32. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy. Barron AU; Hoskin TL; Boughey JC Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095 [TBL] [Abstract][Full Text] [Related]
33. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study. Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843 [TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy. Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504 [TBL] [Abstract][Full Text] [Related]
35. Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes? Costarelli L; Arienzo F; Broglia L; La Pinta M; Scavina P; Meli EZ; Colavito MH; Ascarelli A; Campagna D; Mastropietro T; Manna E; Amato M; Andrulli AD; Schiavone A; Minelli M; Fortunato L Ann Surg Oncol; 2024 May; 31(5):3186-3193. PubMed ID: 38427160 [TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach. Damin AP; Zancan M; Melo MP; Biazus JV Breast Cancer Res Treat; 2021 Apr; 186(2):527-534. PubMed ID: 33165710 [TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483 [TBL] [Abstract][Full Text] [Related]
38. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer. Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955 [TBL] [Abstract][Full Text] [Related]
39. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma. Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376 [TBL] [Abstract][Full Text] [Related]
40. Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy. Lohani KR; Hoskin TL; Yasir S; Olson CA; Boughey JC; Hieken TJ; Degnim AC Ann Surg Oncol; 2024 Oct; 31(11):7431-7440. PubMed ID: 39120840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]